Russell P. Rother
President presso Tetherex Pharmaceuticals Corp.
Profilo
Russell P.
Rother is currently the Director at Moat Biotechnology Corp.
and the President & Chief Operating Officer at Tetherex Pharmaceuticals Corp.
Previously, he worked as the Director at Gene Technologies Ltd.
from 1996 to 1999, Senior Vice President-Research at Alexion Pharmaceuticals, Inc. from 1999 to 2009, and as the Chief Operating Officer & Executive Vice President at Selexys Pharmaceuticals Corp.
Posizioni attive di Russell P. Rother
Società | Posizione | Inizio |
---|---|---|
Tetherex Pharmaceuticals Corp.
Tetherex Pharmaceuticals Corp. BiotechnologyHealth Technology Tetherex Pharmaceuticals Corp. operates as a biopharmaceutical company. It focuses on development of therapeutics for the treatment of thrombosis, inflammation and tumor metastasis across a broad range of severe diseases. The company was founded by Rodger P. McEver and Richard D. Cummings and is headquartered in Oklahoma City, OK. | President | - |
Moat Biotechnology Corp.
Moat Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Moat Biotechnology Corp. is a biopharmaceutical company that focuses on developing vaccines. The company is based in Oklahoma City, OK. | Director/Board Member | - |
Precedenti posizioni note di Russell P. Rother
Società | Posizione | Fine |
---|---|---|
Gene Technologies Ltd.
Gene Technologies Ltd. Gene Technologies Ltd. operated as a molecular diagnostics company. The company was headquartered in Braintree, the United Kingdom. | Director/Board Member | 01/01/1999 |
Selexys Pharmaceuticals Corp.
Selexys Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK. | Chief Operating Officer | - |
ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Selexys Pharmaceuticals Corp.
Selexys Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK. | Health Technology |
Tetherex Pharmaceuticals Corp.
Tetherex Pharmaceuticals Corp. BiotechnologyHealth Technology Tetherex Pharmaceuticals Corp. operates as a biopharmaceutical company. It focuses on development of therapeutics for the treatment of thrombosis, inflammation and tumor metastasis across a broad range of severe diseases. The company was founded by Rodger P. McEver and Richard D. Cummings and is headquartered in Oklahoma City, OK. | Health Technology |
Gene Technologies Ltd.
Gene Technologies Ltd. Gene Technologies Ltd. operated as a molecular diagnostics company. The company was headquartered in Braintree, the United Kingdom. | |
Moat Biotechnology Corp.
Moat Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Moat Biotechnology Corp. is a biopharmaceutical company that focuses on developing vaccines. The company is based in Oklahoma City, OK. | Health Technology |
- Borsa valori
- Insiders
- Russell P. Rother